Centers for Medicare & Medicaid Services (CMS) approved coverage for NGS as a diagnostic laboratory test in March this year, including Thermo Fisher’s Oncomine Dx Target Test, some payers still consider NGS explorative. As some in attendance pointed out, CMS’s decision to supp...
203.Min JK, Shaw LJ, Berman DS, et al. Costs and clinical outcomes in individuals without known coronary artery disease undergoing coronary computed tomographic angiography from an analysis of Medicare category III transaction codes. Am J Cardiol. 2008;102:672–8. 204.Ladapo JA, Hoffmann U, B...